Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEARCA:AVMVNYSEARCA:CZANASDAQ:FNKNYSEARCA:IQSM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVMVAvantis U.S. Mid Cap Value ETF$64.43+1.3%$61.12$52.42▼$71.74$202.31M0.9520,390 shs10,123 shsCZAInvesco Zacks Mid-Cap ETF$104.86+0.9%$101.95$90.08▼$113.72$184.56M0.883,323 shs2,287 shsFNKFirst Trust Mid Cap Value AlphaDEX Fund$51.23+1.2%$48.82$42.68▼$58.52$199.80M1.2913,996 shs9,161 shsIQSMNYLI Candriam U.S. Mid Cap Equity ETF$31.75-0.6%$30.52$26.78▼$35.34$209.52M1.257,478 shs48 shsInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVMVAvantis U.S. Mid Cap Value ETF0.00%-1.01%-1.88%+2.76%+7.70%CZAInvesco Zacks Mid-Cap ETF0.00%-1.43%-2.55%-0.59%+7.37%FNKFirst Trust Mid Cap Value AlphaDEX Fund0.00%-0.08%-1.99%-0.22%+0.71%IQSMNYLI Candriam U.S. Mid Cap Equity ETF0.00%-1.88%-2.85%+0.54%+4.43%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAVMVAvantis U.S. Mid Cap Value ETFN/AN/AN/AN/AN/AN/AN/AN/ACZAInvesco Zacks Mid-Cap ETFN/AN/AN/AN/AN/AN/AN/AN/AFNKFirst Trust Mid Cap Value AlphaDEX FundN/AN/AN/AN/AN/AN/AN/AN/AIQSMNYLI Candriam U.S. Mid Cap Equity ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAVMVAvantis U.S. Mid Cap Value ETF 2.55Moderate Buy$64.42N/ACZAInvesco Zacks Mid-Cap ETF 2.57Moderate Buy$104.84N/AFNKFirst Trust Mid Cap Value AlphaDEX Fund 2.51Moderate Buy$51.230.01% UpsideIQSMNYLI Candriam U.S. Mid Cap Equity ETF 2.62Moderate Buy$31.75N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAVMVAvantis U.S. Mid Cap Value ETFN/AN/AN/AN/AN/AN/ACZAInvesco Zacks Mid-Cap ETFN/AN/AN/AN/AN/AN/AFNKFirst Trust Mid Cap Value AlphaDEX FundN/AN/AN/AN/AN/AN/AIQSMNYLI Candriam U.S. Mid Cap Equity ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAVMVAvantis U.S. Mid Cap Value ETFN/AN/A15.67∞N/AN/AN/AN/AN/ACZAInvesco Zacks Mid-Cap ETFN/AN/A18.82∞N/AN/AN/AN/AN/AFNKFirst Trust Mid Cap Value AlphaDEX FundN/AN/A10.85∞N/AN/AN/AN/AN/AIQSMNYLI Candriam U.S. Mid Cap Equity ETFN/AN/A20.02∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAVMVAvantis U.S. Mid Cap Value ETF$0.881.37%N/AN/AN/ACZAInvesco Zacks Mid-Cap ETF$1.321.26%N/AN/AN/AFNKFirst Trust Mid Cap Value AlphaDEX Fund$0.931.82%N/AN/AN/AIQSMNYLI Candriam U.S. Mid Cap Equity ETF$0.381.20%N/AN/AN/ALatest AVMV, FNK, CZA, and IQSM DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/26/2025FNKFirst Trust Mid Cap Value AlphaDEX FundQuarterly$0.17461.37%3/27/20253/27/20253/31/2025(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAVMVAvantis U.S. Mid Cap Value ETFN/ACZAInvesco Zacks Mid-Cap ETFN/AFNKFirst Trust Mid Cap Value AlphaDEX FundN/AIQSMNYLI Candriam U.S. Mid Cap Equity ETFN/AInsider OwnershipCompanyInsider OwnershipAVMVAvantis U.S. Mid Cap Value ETFN/ACZAInvesco Zacks Mid-Cap ETFN/AFNKFirst Trust Mid Cap Value AlphaDEX FundN/AIQSMNYLI Candriam U.S. Mid Cap Equity ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAVMVAvantis U.S. Mid Cap Value ETFN/A3.14 millionN/AN/ACZAInvesco Zacks Mid-Cap ETFN/A1.76 millionN/ANot OptionableFNKFirst Trust Mid Cap Value AlphaDEX FundN/A3.90 millionN/AOptionableIQSMNYLI Candriam U.S. Mid Cap Equity ETFN/A6.60 millionN/ANot OptionableAVMV, FNK, CZA, and IQSM HeadlinesRecent News About These CompaniesNo headlines for this company have been tracked by MarketBeat.comMedia Sentiment Over TimeAVMV, FNK, CZA, and IQSM Company DescriptionsAvantis U.S. Mid Cap Value ETF NYSEARCA:AVMV$64.43 +0.82 (+1.29%) Closing price 03:59 PM EasternExtended Trading$64.41 -0.02 (-0.03%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Avantis U.S. Mid Cap Value ETF (AVMV) is an exchange-traded fund that mostly invests in mid cap equity. The fund seeks long-term capital appreciation through an actively managed portfolio of US mid-cap value companies selected based on fundamental criteria. AVMV was launched on Nov 7, 2023 and is issued by American Century Investments.Invesco Zacks Mid-Cap ETF NYSEARCA:CZA$104.86 +0.91 (+0.88%) Closing price 03:59 PM EasternExtended Trading$104.96 +0.10 (+0.09%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Guggenheim Mid-Cap Core ETF (the Fund), formerly Claymore/Zacks Mid-Cap Core ETF, seeks investment results that correspond generally to the performance of an index called the Zacks Mid-Cap Core Index (the Index). The Fund will invest at least 90% of its total assets in securities that comprise the Index and depositary receipts representing securities that comprise the Index (or underlying securities representing ADRs that comprise the Index). The Index is comprised of 100 securities selected, based on investment and other criteria, from a universe of mid-capitalization common stocks, including master limited partnerships (MLPs), and American depositary receipts (ADRs). The depositary receipts included in the Index may be sponsored or unsponsored. The Fund's investment advisor is Guggenheim Funds Investment Advisors, LLC.First Trust Mid Cap Value AlphaDEX Fund NASDAQ:FNK$51.23 +0.60 (+1.19%) Closing price 03:52 PM EasternExtended Trading$51.25 +0.02 (+0.04%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The First Trust Mid Cap Value AlphaDEX Fund (FNK) is an exchange-traded fund that is based on the NASDAQ AlphaDEX Mid Cap Value index. The fund tracks a mid-cap index that selects value stocks using quant methodology and applies an equal-tiered weighting scheme. FNK was launched on Apr 18, 2011 and is managed by First Trust.NYLI Candriam U.S. Mid Cap Equity ETF NYSEARCA:IQSM$31.75 -0.20 (-0.64%) As of 03:08 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.The Iq Candriam ESG U.S. Mid Cap Equity ETF (IQSM) is an exchange-traded fund that is based on the IQ Candriam ESG U.S. Mid Cap Equity index. The fund tracks a market cap-weighted index that provides exposure to US mid-cap stocks that meet environmental, social, and corporate governance criteria. IQSM was launched on Oct 25, 2022 and is managed by IndexIQ. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir Defies Bears, Leads S&P 500 in 2025 AST SpaceMobile’s Star Is Rising: Get in While It’s Still Cheap! Could Meta and Eli Lilly Trigger the Next Stock Split Boom? Iran Conflict Fuels Fertilizer Stocks’ Bullish Setup Is D-Wave's Latest $400M Sales Agreement a Dilution Deal-Breaker? Why Analysts Are Bullish on Celsius Stock After 30% Drop 3 Stocks With Rising Dividends Investors Shouldn’t Ignore SoundHound’s AI Growth Story Is Just Getting Started Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
